423. The Doctor Will Zoom You Now

Episode Summary

Executive Summary: The episode examines how COVID-19 abruptly accelerated telehealth from a niche option into a mainstream mode of care, using physician experience, regulatory shifts, and health-economics analysis. It explores which visits work virtually, which still require in-person care, how reimbursement and policy changes enabled adoption, and whether telehealth will persist after the pandemic as a tool for convenience, prevention, and cost control.

Main Topics: Pandemic-driven shift in primary care (Priority: 5/5): Dr. Rebecca Kurth describes how her routine preventive practice turned into a high-volume stream of COVID-related phone triage and virtual follow-up during New York City’s peak outbreak. What telehealth can and cannot do (Priority: 5/5): The conversation distinguishes effective telehealth use cases such as back pain, rashes, blood pressure follow-up, and algorithmic sick visits from conditions that still require in-person examination or emergency care. Regulatory and reimbursement changes (Priority: 5/5): Chad Elimoodle explains that federal and state rule changes—home access, relaxed privacy rules, parity reimbursement, licensure flexibility, and waived copays—were essential to telehealth’s rapid adoption. Economics of telehealth adoption (Priority: 5/5): David Cutler argues the biggest barrier had been financial, not technological or patient demand, and that payment policy will largely determine whether telehealth remains embedded after the crisis. Telehealth’s effects on costs and health outcomes (Priority: 4/5): The episode weighs possible savings from reduced overhead and avoided institutional care against concerns that telehealth may lower revenue by eliminating in-person add-ons and could worsen inequities. Prevention, remote monitoring, and AI (Priority: 4/5): Speakers suggest telehealth could strengthen chronic disease management and preventive care through home monitoring, medication adherence support, and data-driven tools like AI. Winners, losers, and long-term system change (Priority: 4/5): Potential winners include patients and flexible physicians; losers may include office-space landlords, support staff, and ancillary service businesses. The old all-in-person model is portrayed as obsolete.

Key Arguments: Telehealth became indispensable during the COVID peak because physicians needed a safe way to triage, reassure, and monitor patients without increasing infection risk. Many common problems can be handled virtually because they follow recognizable clinical algorithms and require limited physical examination. Some symptoms and emergencies—ear pain, chest pain, stroke signs, and many abdominal pain cases—still demand in-person assessment or the ER. The most important barrier to telehealth before COVID was reimbursement and regulation, not lack of technology or patient interest. Federal emergency policy changes dramatically reduced friction by allowing care from home, relaxing HIPAA enforcement, enabling cross-state practice, and paying for telehealth similarly to in-person visits. Telehealth may lower system costs by reducing office overhead and especially by keeping patients out of expensive institutions such as hospitals and ICUs. At the same time, telehealth can reduce revenue for practices that depend on in-office ancillary services and screenings that do not translate into virtual care. Remote monitoring has the strongest evidence in chronic conditions like heart failure and diabetes, where it can improve outcomes and reduce hospital use. Telehealth is likely to persist after the pandemic, but at a lower level than the peak, becoming a durable supplement rather than a total replacement for in-person care. If telehealth expands without safeguards, it could initially widen inequalities because higher-income, better-connected patients are more able to access and benefit from it.

Data Points: COVID-related patients in Dr. Kurth’s practice: about 50 out of 1,000 patients - She estimated roughly 50 patients in her panel had COVID-related illness during the peak Daily symptom calls during peak: 8 to 10 patients per day - Her practice shifted from occasional fever discussions to frequent COVID triage calls Peak NYC COVID deaths: as many as 800 people a day - Used to describe the severity of the outbreak in New York City University of Michigan telehealth volume pre-pandemic: about 400 visits per month - Baseline telehealth use before COVID University of Michigan telehealth volume in April: 30,000 visits - Volume surged during the pandemic University of Michigan telehealth volume in May: about 40,000 visits - Telehealth remained extremely high after the initial surge Michigan insurer telehealth encounters pre-pandemic: about 10,000 per month - Statewide insurance data before COVID Michigan insurer telehealth encounters in March: 140,000 - Sharp pandemic-era increase in telehealth use Michigan insurer telehealth encounters in April: 230,000 - Peak state-level telehealth activity in the data cited Medicare telehealth utilization before COVID: less than 1% of Medicare patients ever used telehealth - Illustrates how limited telehealth adoption had been before the pandemic Projected future telehealth share (Cutler/Kurth discussion): about 25% - Estimate of the share of visits that could convert to telehealth by 2025 Current telehealth share during crisis: 10% to 15% of medical visits - David Cutler’s estimate of the pandemic-era level U.S. healthcare spending share of GDP: about 18% - The U.S. spends this share of GDP on healthcare in a typical year Annual U.S. healthcare spending: $3.5 trillion - Used to frame the scale of the healthcare system Estimated unnecessary healthcare spending: $1 trillion per year - Cutler’s estimate of waste that could potentially be reduced Population without insurance: 27 million Americans - Referenced when discussing access barriers to medical care Chronic disease treatment gap: about half - Only about half of people with high cholesterol or hypertension are successfully treated

Pivotal Quotes: "I really think that the old model of bringing patients in for every medical reason is over." — Dr. Rebecca Kurth: Her view that telehealth will remain part of routine care after COVID "The key missing ingredient had always been the financial one." — David Cutler: Explaining why telehealth adoption lagged before the pandemic "If you want to reduce spending in medical care, get people out of institutions." — David Cutler: On the biggest opportunity for cost reduction in U.S. healthcare

Implications: Telehealth is likely to stay as a permanent layer of care, especially for follow-ups, chronic disease management, and prevention. Its long-term impact will depend on reimbursement policy, equity safeguards, and whether systems can shift care away from expensive institutions without harming outcomes.